Phase 2 Study of ONC201 in Neuroendocrine Tumors

Clinical trial NCT03034200 · COMPLETED

Trial details

NCT number: NCT03034200
Sponsor: Peter Anderson
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Neuroendocrine Tumor Metastatic Neuroendocrine Tumor

Start date: 2017-08-02
Primary completion: 2023-05-19
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.